- Home
- AZTA vs WGS Comparison
AZTA vs WGS Comparison
Compare AZTA & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTA
- WGS
- Stock Information
- Founded
- AZTA 1978
- WGS 2017
- Country
- AZTA United States
- WGS United States
- Employees
- AZTA N/A
- WGS N/A
- Industry
- AZTA Industrial Machinery/Components
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- AZTA Technology
- WGS Technology
- Exchange
- AZTA Nasdaq
- WGS Nasdaq
- Market Cap
- AZTA 2.4B
- WGS 2.0B
- IPO Year
- AZTA 1995
- WGS N/A
- Fundamental
- Price
- AZTA $52.63
- WGS $69.48
- Analyst Decision
- AZTA Buy
- WGS Strong Buy
- Analyst Count
- AZTA 5
- WGS 5
- Target Price
- AZTA $61.60
- WGS $80.60
- AVG Volume (30 Days)
- AZTA 595.5K
- WGS 787.4K
- Earning Date
- AZTA 02-05-2025
- WGS 02-18-2025
- Dividend Yield
- AZTA N/A
- WGS N/A
- EPS Growth
- AZTA N/A
- WGS N/A
- EPS
- AZTA N/A
- WGS N/A
- Revenue
- AZTA $656,323,000.00
- WGS $267,228,000.00
- Revenue This Year
- AZTA N/A
- WGS $43.70
- Revenue Next Year
- AZTA $6.32
- WGS $17.28
- P/E Ratio
- AZTA N/A
- WGS N/A
- Revenue Growth
- AZTA N/A
- WGS 29.41
- 52 Week Low
- AZTA $38.82
- WGS $2.85
- 52 Week High
- AZTA $69.16
- WGS $98.87
- Technical
- Relative Strength Index (RSI)
- AZTA 64.67
- WGS 40.28
- Support Level
- AZTA $50.79
- WGS $66.81
- Resistance Level
- AZTA $53.47
- WGS $98.87
- Average True Range (ATR)
- AZTA 1.78
- WGS 7.98
- MACD
- AZTA 0.01
- WGS -2.10
- Stochastic Oscillator
- AZTA 75.83
- WGS 8.33
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.